Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-000243

REGENXBIO Inc. · RGNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Patrick J. Christmas
Officer — SVP, General Counsel
Period of report
Jun 30, 2017
Accepted (ET)
Jan 5, 2018 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 30, 2017A655$15.725A655D
Common StockF3,F4Dec 29, 2017A486$17.425A1,141D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$35.80Jan 3, 2018A43,000A—Jan 3, 2028Common Stock43,00043,000D

Explanation of responses